Pierre Charles Alexandre Louis

This MedLibrary.org supplementary page on Pierre Charles Alexandre Louis is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Pierre Charles Alexandre Louis (1787-1872) was a French physician, known for introducing the use of numerical method in the field of medicine, that is, the idea that knowledge about the disease, its history, clnical presentation and treatment could be derived from aggregated patients data. He became known for his research on tuberculosis and typhoid fever and for the controversy that opposed him to François Joseph Victor Broussais about the use of bloodletting in the treatment of pneumonitis (today pneumonia). It was in 1835 that Louis published Researches sur les effets de la saigneé dans quelques maladies inflammatoires in which he utilized the numerical method to prove that bloodletting was an ineffective treatment for the various fevers.

References Morabia A (2004). Pierre-Charles-Alexandre Louis and the evaluation of bloodletting. The James Lind Library (www.jameslindlibrary.org) Accessed Thursday 31 August 2006.


Wikipedia content modification information:

  • This page was last modified on 19 September 2008, at 03:52.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Pierre Charles Alexandre Louis".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.